Source:http://linkedlifedata.com/resource/pubmed/id/15829258
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2005-4-14
|
pubmed:abstractText |
Clinically used somatostatin (SRIF) analogs, octreotide and lanreotide, act primarily by binding to SRIF receptor subtype 2 (sst2). In contrast, the recently described multiligand SOM230 binds with high affinity to sst(1-3) and sst5 and KE 108 is characterised as a high affinity ligand for all five SRIF receptors. In tumoural mouse corticotrophs (AtT-20 cells) and in mouse hippocampus, binding and functional features of KE 108 were examined and compared to SRIF-14, octreotide and SOM230. In AtT-20 cells, KE 108 bound with high affinity at [125I]LTT-SRIF-28-labelled sites similarly to SRIF-14, octreotide and SOM230. At the functional level, all four ligands increased guanosine-5'-O-(3-[35S]thio)-triphosphate binding and decreased cAMP accumulation or intracellular Ca2+ concentration through G(i/o) proteins. In hippocampal slices, KE 108, octreotide and SOM230 also bound with high affinity at [125I]LTT-SRIF-28-labelled sites similarly to SRIF-14, but KE 108, octreotide or SOM230 did not influence spontaneous epileptiform activity which was, in contrast, inhibited by SRIF-14. In conclusion, this study demonstrates that KE 108 has high affinity for native mouse SRIF receptors. Functionally, KE 108 mediates SRIF action at sst(2/5) in corticotrophs whereas it does not mimic the SRIF-induced inhibition of hippocampal excitation suggesting that the high potency and efficacy of a synthetic ligand to all known SRIF receptors may not reproduce entirely the effects of the natural SRIF.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP,
http://linkedlifedata.com/resource/pubmed/chemical/Fura-2,
http://linkedlifedata.com/resource/pubmed/chemical/Guanosine 5'-O-(3-Thiotriphosphate),
http://linkedlifedata.com/resource/pubmed/chemical/Peptides, Cyclic,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Somatostatin,
http://linkedlifedata.com/resource/pubmed/chemical/Somatostatin,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfur Isotopes,
http://linkedlifedata.com/resource/pubmed/chemical/Tyr(0)-(cyclo-D-Dab-Arg-Phe-Phe-D-Tr...,
http://linkedlifedata.com/resource/pubmed/chemical/fura-2-am
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0028-3908
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
881-93
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15829258-Animals,
pubmed-meshheading:15829258-Calcium,
pubmed-meshheading:15829258-Cell Line, Tumor,
pubmed-meshheading:15829258-Cyclic AMP,
pubmed-meshheading:15829258-Dose-Response Relationship, Drug,
pubmed-meshheading:15829258-Female,
pubmed-meshheading:15829258-Fura-2,
pubmed-meshheading:15829258-Guanosine 5'-O-(3-Thiotriphosphate),
pubmed-meshheading:15829258-Hippocampus,
pubmed-meshheading:15829258-Male,
pubmed-meshheading:15829258-Mice,
pubmed-meshheading:15829258-Peptides, Cyclic,
pubmed-meshheading:15829258-Protein Binding,
pubmed-meshheading:15829258-Radioligand Assay,
pubmed-meshheading:15829258-Receptors, Somatostatin,
pubmed-meshheading:15829258-Somatostatin,
pubmed-meshheading:15829258-Sulfur Isotopes,
pubmed-meshheading:15829258-Time Factors
|
pubmed:year |
2005
|
pubmed:articleTitle |
Binding and functional properties of the novel somatostatin analogue KE 108 at native mouse somatostatin receptors.
|
pubmed:affiliation |
Dipartimento di Fisiologia e Biochimica G. Moruzzi, Università di Pisa, 56127 Pisa, Italy. d.cervia@dfb.unipi.it
|
pubmed:publicationType |
Journal Article,
Comparative Study,
In Vitro,
Research Support, Non-U.S. Gov't
|